Risk prediction in early triple negative breast cancer

被引：0
|
作者：
Mason, Sofia [1 ,2 ]
机构：
[1] Chris OBrien Lifehouse, Sydney, NSW, Australia
[2] UNSW Sydney, Garvan Inst Med Res, St Vincents Healthcare Clin Campus, Sydney, NSW, Australia
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2024年 / 387卷
关键词：
SIGNATURE;
D O I：
10.1136/bmj.q2088
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] microRNA expression and recurrence risk prediction in Triple Negative Breast Cancer patients
    AbdulAziz, AhamdAizat
    MdSalleh, MdSalzihan
    Mohamad, Ibtisam
    Bhavaraju, VenkataMuraliKrishna
    Gan, SiewHua
    Ankathil, Ravindran
    ANNALS OF ONCOLOGY, 2017, 28
  • [2] Early prediction of response to Neoadjuvant Immunotherapy in Triple Negative Breast Cancer (TNBC) with DCEMRI
    Rauch, Gaiane
    Guirguis, Mary
    Patel, Miral
    Candelaria, Rosalind
    Mohamed, Rania
    Moseley, Tanya
    Le-Petross, H. T. Carisa
    Leung, Jessica
    Whitman, Gary
    Lane, Deanna
    Scoggins, Marion
    Perez, Frances
    Sun, Jia
    Pashapoor, Sanaz
    Xu, Zhan
    White, Jason
    Wei, Peng
    Reed, Brandy
    Son, Jong Bum
    Hwang, Ken-Pin
    Panthi, Bikash
    Korkut, Anil
    Huo, Lei
    Hunt, Kelly
    Clayborn, Alyson
    Litton, Jennifer
    Valero, Vicente
    Tripathy, Debu
    Yam, Clinton
    Yang, Wei
    Ma, Jingfei
    Adrada, Beatriz
    CANCER RESEARCH, 2024, 84 (09)
  • [3] Carboplatin for early triple- negative breast cancer?
    Valero, Vicente
    LANCET ONCOLOGY, 2014, 15 (07): : 676 - 678
  • [4] Pembrolizumab for Early Triple-Negative Breast Cancer
    Schmid, Peter
    Cortes, Javier
    Pusztai, Lajos
    McArthur, Heather
    Kuemmel, Sherko
    Bergh, Jonas
    Denkert, Carsten
    Park, Yeon Hee
    Hui, Rina
    Harbeck, Nadia
    Takahashi, Masato
    Foukakis, Theodoros
    Fasching, Peter A.
    Cardoso, Fatima
    Untch, Michael
    Jia, Liyi
    Karantza, Vassiliki
    Zhao, Jing
    Aktan, Gursel
    Dent, Rebecca
    O'Shaughnessy, Joyce
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (09): : 810 - 821
  • [5] Neoadjuvant eribulin in early triple negative breast cancer
    Naito, Y.
    Yonemori, K.
    Yamamoto, H.
    Takahashi, M.
    Nakamura, R.
    Masuda, N.
    Aogi, K.
    Yamanaka, T.
    Ito, Y.
    Yoshida, A.
    Tsuda, H.
    Kuchiba, A.
    Hata, T.
    Tamura, K.
    Fujiwara, Y.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S97 - S98
  • [6] Pembrolizumab for Early Triple-Negative Breast Cancer
    Cetin, Bulent
    Gumusay, Ozge
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (26):
  • [7] Integrated model for early prediction of neoadjuvant systemic therapy response in triple negative breast cancer
    Rauch, Gaiane Margishvili
    Candelaria, Rosalind P.
    Guirguis, Mary Saber
    Boge, Medine
    Mohamed, Rania M. M.
    Elshafeey, Nabil
    Sun, Jia
    Whitman, Gary J.
    Leung, Jessica
    Le-Petross, Huong C.
    Santiago, Lumarie
    Lane, Deanna
    Scoggins, Marion
    Spak, David
    Patel, Miral M.
    Perez, Frances
    White, Jason B.
    Ravenberg, Elizabeth
    Peng, Wei
    Tripathy, Debu
    Valero, Vicente
    Litton, Jennifer
    Huo, Lei
    Yam, Clinton
    Thompson, Alastair
    Ma, Jingfei
    Moulder, Stacy L.
    Yang, Wei
    Adrada, Beatriz E.
    CANCER RESEARCH, 2022, 82 (04)
  • [8] Prediction and screening of circRNA in triple-negative breast cancer
    Li, Xuanhe
    Zhang, Song
    Sun, Siyu
    Yue, Xicheng
    Qian, Liyu
    Tang, Jie
    Jiang, Fangqian
    Lu, Jianfei
    Cao, Yifan
    Meng, Shengwen
    Yao, Tingjing
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (11): : 8049 - 8063
  • [9] Identification of Prognostic Genes for Recurrent Risk Prediction in Triple Negative Breast Cancer Patients in Taiwan
    Chen, Lee H.
    Kuo, Wen-Hung
    Tsai, Mong-Hsun
    Chen, Pei-Chun
    Hsiao, Chuhsing K.
    Chuang, Eric Y.
    Chang, Li-Yun
    Hsieh, Fon-Jou
    Lai, Liang-Chuan
    Chang, King-Jen
    PLOS ONE, 2011, 6 (11):
  • [10] Update on systemic treatment in early triple negative breast cancer
    Nunez Abad, Martin
    Calabuig-Farinas, Silvia
    Lobo de Mena, Miriam
    Sanz de Bremond, Maria Jose Godes
    Garcia Gonzalez, Clara
    Torres Martinez, Susana
    Angel Garcia-Garcia, Jose
    Iranzo Gonzalez-Cruz, Vega
    Camps Herrero, Carlos
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
12345